Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tokyo Showa Clinic is a specialized medical facility located in the Ginza district of Tokyo, Japan, focusing on advanced cancer immunotherapy and regenerative medicine. The clinic provides personalized treatment options such as Autologous Natural Killer (NK) Cell Therapy, Dendritic Cell (DC) Vaccine Therapy, and Alpha-Beta T-cell therapy. These treatments utilize the patient's own immune system to target and eliminate cancer cells, often used as a complement to standard therapies like surgery, radiation, and chemotherapy. The clinic is operated by the Medical Corporation Showakai and serves both domestic and international patients seeking innovative oncological care. Its services emphasize a patient-centered approach to improving quality of life and treatment outcomes through cellular medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tokyo Showa Clinic.